SynthesisFrontiers in immunology2025

Meta-analysis of the efficacy and safety of rituximab in the treatment of primary Sjögren's syndrome.

Xiao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.